
- February 2020
- Volume 87
- Issue 2
CE: A Pharmacist's Guide to Effective Management of Hyperkalemia
This activity is supported by an educational grant from AstraZeneca.
This activity is supported by an educational grant from AstraZeneca.
FACULTY
Todd Brothers, PharmD, BCCCP, BCPS, Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Rhode Island College of Pharmacy in Kingston, Rhode Island
EDUCATIONAL OBJECTIVES
At the completion of this activity, the participant will be able to:
- Explain the etiology and identify patients at risk for hyperkalemia
- Identify methods to effectively treat hyperkalemia and develop recommendations for use in clinical practice
- Examine strategies to improve care and outcomes in patients with hyperkalemia
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: February 14, 2020
EXPIRATION DATE: February 14, 2021
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This less is offered for free at
Articles in this issue
over 5 years ago
Interactives: Case Studies (February 2020)over 5 years ago
Clinical Pharmacology Update: Xenleta from Nabriva Therapeuticsover 5 years ago
Can a Patient with HIV Maintain a Lawsuit?over 5 years ago
Help Teens Who Struggle With Depressionover 5 years ago
Study Results Link Postpartum Depression to Inflammationover 5 years ago
Clinical Evidence Exists for Allopregnanolone-based Treatmentsover 5 years ago
Pet Peevesover 5 years ago
Nonprofit Addresses Commonsense Prescribingover 5 years ago
Advanced Education and Training Opportunities IncreaseNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































